CN104311689B - 一种黄芪多糖的提取方法 - Google Patents
一种黄芪多糖的提取方法 Download PDFInfo
- Publication number
- CN104311689B CN104311689B CN201410628522.6A CN201410628522A CN104311689B CN 104311689 B CN104311689 B CN 104311689B CN 201410628522 A CN201410628522 A CN 201410628522A CN 104311689 B CN104311689 B CN 104311689B
- Authority
- CN
- China
- Prior art keywords
- radix astragali
- enzymolysis
- astragalus
- polysaccharides
- microwave
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 69
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 69
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 69
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 53
- 241001061264 Astragalus Species 0.000 title claims abstract description 29
- 210000004233 talus Anatomy 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 28
- 239000009636 Huang Qi Substances 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 27
- 229940088598 enzyme Drugs 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 25
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 24
- 238000000605 extraction Methods 0.000 claims abstract description 20
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 17
- 108010004032 Bromelains Proteins 0.000 claims abstract description 17
- 108010059892 Cellulase Proteins 0.000 claims abstract description 17
- 239000004365 Protease Substances 0.000 claims abstract description 17
- 235000019835 bromelain Nutrition 0.000 claims abstract description 17
- 229940106157 cellulase Drugs 0.000 claims abstract description 17
- 230000007062 hydrolysis Effects 0.000 claims abstract description 16
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 16
- 238000001556 precipitation Methods 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 15
- 239000006228 supernatant Substances 0.000 claims abstract description 15
- 238000010298 pulverizing process Methods 0.000 claims abstract description 10
- 239000012141 concentrate Substances 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 43
- 238000001914 filtration Methods 0.000 claims description 14
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 10
- 230000006837 decompression Effects 0.000 claims description 7
- 238000012869 ethanol precipitation Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002893 slag Substances 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract description 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000010926 purge Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229940107666 astragalus root Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000006758 Marek Disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000002799 interferon inducing agent Substances 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 229960003243 phenformin Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410628522.6A CN104311689B (zh) | 2014-11-11 | 2014-11-11 | 一种黄芪多糖的提取方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410628522.6A CN104311689B (zh) | 2014-11-11 | 2014-11-11 | 一种黄芪多糖的提取方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104311689A CN104311689A (zh) | 2015-01-28 |
CN104311689B true CN104311689B (zh) | 2016-12-28 |
Family
ID=52367018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410628522.6A Active CN104311689B (zh) | 2014-11-11 | 2014-11-11 | 一种黄芪多糖的提取方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104311689B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105440149A (zh) * | 2015-12-14 | 2016-03-30 | 陈燕妮 | 利用酶解微波技术生产黄芪多糖的工艺 |
CN108066354A (zh) * | 2016-11-10 | 2018-05-25 | 怀特生技新药股份有限公司 | 黄芪多糖萃取物在制备用于增强癌症免疫疗法功效的药物中的用途 |
CN108236032A (zh) * | 2017-03-16 | 2018-07-03 | 楚雄云植药业有限公司 | 一种三七多糖压片糖果及其制备方法 |
CN106858598A (zh) * | 2017-04-01 | 2017-06-20 | 吉林大学 | 一种专供产妇食用的微胶囊化速溶保健食品及其制备方法 |
CN108084288A (zh) * | 2017-12-26 | 2018-05-29 | 浦江县美泽生物科技有限公司 | 高效的黄芪多糖提取方法 |
CN108497222A (zh) * | 2018-01-31 | 2018-09-07 | 东兰县百花园原生态养蜂场 | 一种蜜蜂饲料及其制作方法 |
CN109043053B (zh) * | 2018-09-27 | 2022-06-14 | 广州汝丽多食品科技有限公司 | 一种黄芪茶粉及其制备方法 |
CN112891384A (zh) * | 2021-02-02 | 2021-06-04 | 中国人民解放军联勤保障部队第九八〇医院 | 一种超微粉代替部分辅料的茯苓配方颗粒的制备方法 |
CN113652461A (zh) * | 2021-08-18 | 2021-11-16 | 广东茂骐生物科技有限公司 | 一种黄精植物甾醇多糖蛋白的制备方法及其活性制品 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030072417A (ko) * | 2002-03-04 | 2003-09-15 | 박홍제 | 버섯 균사체와 균사배양액 유래의 기능성 다당류의 추출법및 추출물을 이용한 기능성 차 또는/및 식품의 제조방법 |
CN103288976A (zh) * | 2013-05-15 | 2013-09-11 | 吴惠兰 | 一种高效黄芪多糖的提取方法 |
CN103382228A (zh) * | 2013-07-31 | 2013-11-06 | 瑞普(天津)生物药业有限公司 | 一种高活性黄芪多糖的制备方法 |
-
2014
- 2014-11-11 CN CN201410628522.6A patent/CN104311689B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104311689A (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104311689B (zh) | 一种黄芪多糖的提取方法 | |
CN102964446B (zh) | 一种吸血水蛭活体多次提取天然水蛭素方法 | |
CN102349934B (zh) | 一种虫草菌丝体有效成分的提取工艺 | |
CN102048959A (zh) | 可双向调节人体机能的铁皮石斛复方制剂及其制备方法 | |
CN102293293A (zh) | 滋补肝肾的保健茶及其加工方法 | |
CN105079046A (zh) | 一种全灵芝抗肿瘤软胶囊及其制备方法 | |
CN105017438B (zh) | 一种白背三七多糖及其在制备用于免疫调节和抗肿瘤的药物和功能食品中的应用 | |
CN107184966A (zh) | 一种防治糖尿病及其并发症的药物组合物 | |
CN109125639A (zh) | 治疗痛风的中药组合物 | |
CN104173451B (zh) | 一种天然药物组合物在降血糖药品及保健食品中的应用 | |
CN103584098A (zh) | 玛咖杏仁片及其制备方法 | |
CN103070333B (zh) | 蚕虫草多糖的萃取及其胶囊配制方法 | |
CN105012778A (zh) | 一种铁皮石斛薏苡仁胶囊及其制备方法 | |
CN102670660B (zh) | 九香虫的加工方法及应用 | |
CN109280090B (zh) | 一种具有温肾壮阳活性的九香虫类蝽科昆虫多糖提取方法和应用 | |
CN111437335A (zh) | 一种杀灭非洲猪瘟病毒的植物细胞酶解提取物及其制备方法 | |
CN107411068B (zh) | 一种红枣环磷酸腺苷咀嚼片及其制备方法 | |
CN101829246A (zh) | 提高免疫力的透皮输药贴制剂及其制备方法 | |
CN103948021B (zh) | 一种滁菊明目保健颗粒剂及其生产方法 | |
CN102071239A (zh) | 一种抗肿瘤绿豆多肽及其制备方法和在癌症方面的用途 | |
CN105851764A (zh) | 一种青钱柳叶固体饮料及其制备方法和应用 | |
CN103584060A (zh) | 一种多元调味竹盐及其制备方法 | |
CN106954719A (zh) | 一种桑葚茶及其制备方法 | |
CN101703536A (zh) | 一种螺旋藻多糖与银杏叶有效成分组合的抗肿瘤药物 | |
CN111603522A (zh) | 一种具有降血糖作用的辣椒叶组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Xu Inventor before: Chi Zonglei Inventor before: Cang Weigong Inventor before: Ding Zhenyang |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160922 Address after: 266000 Shandong Province, Licang District, No. nine East Road, No. 320, building 205, room 2 Applicant after: Qingdao Shenda multi-creation Technology Service Co. Ltd. Address before: Watson Road, Licheng District 250100 in Shandong city of Ji'nan province No. 389 building 401. Applicant before: JINAN CAVIN BIOTECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Qing Inventor before: Wang Xu |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170411 Address after: 518028 Guangdong city of Shenzhen province Futian District baguazhang three deep medicine (formerly new Teyao building building 2 floor) Patentee after: Guangdong Kang Li Pharmaceutical Co., Ltd. Address before: 266000 Shandong Province, Licang District, No. nine East Road, No. 320, building 205, room 2 Patentee before: Qingdao Shenda multi-creation Technology Service Co. Ltd. |